|
Market Closed -
NSE India S.E.
15:05:07 24/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,430.40 INR | -1.80% |
|
+0.60% | +19.42% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
| Market Cap | 686B 7.14B 6.28B 5.92B 5.41B 10.11B 10.19B 71.1B 27.55B 349B 26.83B 26.24B 1,136B | P/E 2027 * |
29.6x | P/E 2028 * | 24.6x |
|---|---|---|---|---|---|
| Enterprise Value | 649B 6.76B 5.95B 5.61B 5.12B 9.57B 9.65B 67.31B 26.08B 330B 25.4B 24.85B 1,075B | EV / Sales 2027 * |
3.87x | EV / Sales 2028 * | 3.41x |
| Free-Float |
51.04% | Yield 2027 * |
0.16% | Yield 2028 * | 0.17% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| 532296 | Delayed |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -1.80% | ||
| 1 week | +0.60% | ||
| Current month | -2.00% | ||
| 1 month | +1.66% | ||
| 3 months | +11.46% | ||
| 6 months | +15.97% | ||
| Current year | +19.42% |
| 1 week | 2,422 |  | 2,482.6 |
| 1 month | 2,306.3 | | 2,537.6 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,792.6 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 86 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.80% | +0.60% | +20.40% | +202.74% | 7.29B | |
| -0.81% | -0.93% | +13.69% | +63.37% | 46.71B | |
| +1.45% | +0.72% | +40.00% | +108.41% | 36.9B | |
| +0.87% | +3.98% | +13.93% | +98.17% | 12.18B | |
| +1.16% | +1.65% | -9.04% | +17.97% | 11.66B | |
| 0.00% | -0.95% | +18.72% | +140.74% | 8.97B | |
| -0.16% | -1.02% | +27.26% | +37.50% | 7.21B | |
| +1.91% | +2.68% | +43.74% | -13.82% | 7.09B | |
| -2.45% | +0.10% | -49.83% | +8.04% | 5.12B | |
| -0.80% | +1.11% | +39.83% | +107.49% | 4.65B | |
| Average | -0.07% | +1.35% | +15.87% | +77.06% | 14.78B | |
| Weighted average by Cap. | +0.15% | +0.67% | +19.85% | +79.98% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 168B 1.75B 1.54B 1.45B 1.32B 2.47B 2.49B 17.41B 6.75B 85.46B 6.57B 6.43B 278B | 187B 1.95B 1.71B 1.62B 1.47B 2.76B 2.78B 19.4B 7.52B 95.24B 7.32B 7.16B 310B |
| Net income | 23.11B 241M 212M 200M 182M 341M 343M 2.4B 928M 11.76B 904M 884M 38.27B | 27.71B 289M 254M 239M 218M 408M 412M 2.87B 1.11B 14.1B 1.08B 1.06B 45.89B |
| Net Debt | -36.49B -380M -334M -315M -288M -538M -542M -3.78B -1.47B -18.57B -1.43B -1.4B -60.43B | -48B -500M -440M -415M -378M -707M -713M -4.98B -1.93B -24.43B -1.88B -1.84B -79.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/09/26 | ₹2,430.40 | -1.80% | 453,221 |
| 23/09/26 | ₹2,475.00 | +0.55% | 597,118 |
| 22/09/26 | ₹2,461.40 | +0.47% | 402,355 |
| 21/09/26 | ₹2,450.00 | +0.11% | 405,696 |
| 18/09/26 | ₹2,447.40 | +1.30% | 545,520 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
